BRIEF: Bayzed Health to raise up to $115 million in Hong Kong IPO

Cancer hospital operator Bayzed Health Group Inc. (2609.HK) launched its Hong Kong IPO on Friday, aiming to raise up to HK$900 million ($115 million). The company said it plans to sell 133 million shares at between HK$4.22 and HK$6.75 per share, according to its announcement marking the listing’s launch.

Final pricing will take place on June 19, with trading set to begin on June 23.

Bayzed operates six self-owned hospitals around China engaged in the detection and treatment of cancer. The company reported 1.19 billion yuan ($166 million) in revenue last year, up 11% from 1.07 billion yuan in 2023. Its loss for 2024 narrowed to 13.5 million yuan from a 24.6 million yuan loss the previous year.

By Doug Young

To subscribe to Bamboo Works free weekly newsletter, click here